Dimensional Fund Advisors
CLSD

Dimensional Fund Advisors’s Clearside Biomedical CLSD Stock Holding History

Dimensional Fund Advisors’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,035
Closed -$88K – 3422
2019
Q2 		$88K Hold
6,035
– – ﹤0.01% 3403
2019
Q1 		$125K Hold
6,035
– – ﹤0.01% 3363
2018
Q4 		$97K Hold
6,035
– – ﹤0.01% 3359
2018
Q3 		$557K Buy
+6,035
New +$717K ﹤0.01% 3159

Other funds holding CLSD

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Dimensional Fund Advisors's CLSD Position: Q3 2019 in Review

Dimensional Fund Advisors sold out of Clearside Biomedical (CLSD) in Q3 2019, closing a stake of 6,035 shares — an estimated $88K sold.

Dimensional Fund Advisors first reported a position in CLSD in Q3 2018 and held it in 4 quarters. The position peaked at $557K in Q3 2018. 34 funds tracked by Wall St. Rank hold CLSD as of Q3 2019.

  • Dimensional Fund Advisors reported no remaining Clearside Biomedical position as of Q3 2019 after selling out during the quarter.
  • Dimensional Fund Advisors sold 6,035 Clearside Biomedical shares in Q3 2019, an estimated $88K.
  • Dimensional Fund Advisors first reported a position in Clearside Biomedical in Q3 2018 and held it in 4 quarters.
  • Dimensional Fund Advisors's Clearside Biomedical position peaked at $557K in Q3 2018.
  • 34 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2019.

Based on Dimensional Fund Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.